Author

Miles J. Arnett

University of PennsylvaniaORCID 0000-0003-4532-6066Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:perturbation response prediction· 1 Approach:statistical model· 1

Frequent Co-Authors

Arjun RajiD· 2 shared Benjamin L. EmertiD· 1 shared Christopher J. CoteiD· 1 shared Connie JiangiD· 1 shared Gianna T. BuschiD· 1 shared Ian A. MellisiD· 1 shared Ian P. DardaniiD· 1 shared Jingxin LiiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Arjun RajORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologybioRxivPreprintApr 25, 2025

Heterogeneous therapy-resistant cancer cells have distinct and exploitable drug sensitivity profiles

Gianna T. Busch, Ryan H. Boe, Jingxin Li…·Arjun Raj

The paper shows that therapy-resistant cancer cell clones have distinct drug sensitivity profiles, and combinations targeting these subpopulations can effectively eliminate resistant populations.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Systems BiologyCell SystemsPeer-reviewedFeb 1, 2024

Retrospective identification of intrinsic factors that mark pluripotency potential in rare somatic cells

Naveen Jain, Yogesh Goyal, Margaret C. Dunagin…·Arjun Raj

The paper identifies molecular factors that mark pluripotency potential in rare somatic cells by analyzing fibroblast reprogramming efficiency.

35 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky